NMR Pipeline Methodology Research Team, RIKEN Systems and Structural Biology Center, Suehiro-cho, Tsurumi, Yokohama, Japan.
Bioorg Med Chem. 2012 Nov 15;20(22):6579-82. doi: 10.1016/j.bmc.2012.09.038. Epub 2012 Sep 25.
Immuno-PET is a promising approach for improved cancer diagnosis, by taking advantage of the high specificity of antibodies. Here, we present a novel cell-free protein synthesis method for preparing a positron emitter labeled-antibody. Functional anti-human EGFRvIII single chain Fv, MR1-1, was successfully labeled with carbon-11 (half-life=20.4 min) in 5 min (36% yield) by the direct incorporation of the clinical PET tracer, l-[(11)C]methionine. The product [(11)C]MR1-1 was easily and rapidly isolated with high radiochemical purity (>95%) from the reaction solution, by affinity purification. This method would be widely applicable to the preparation of radiolabeled antibodies for PET imaging.
免疫 PET 是一种很有前途的癌症诊断方法,它利用了抗体的高特异性。在这里,我们提出了一种新的无细胞蛋白合成方法,用于制备正电子发射标记抗体。功能性抗人 EGFRvIII 单链 Fv,MR1-1,通过直接掺入临床 PET 示踪剂 l-[(11)C]蛋氨酸,在 5 分钟内(36%产率)成功地用碳-11(半衰期=20.4 分钟)标记。产物 [(11)C]MR1-1 可通过亲和纯化从反应溶液中轻松快速地分离,具有高放射化学纯度(>95%)。这种方法将广泛适用于制备用于 PET 成像的放射性标记抗体。